UBS Group’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
|
|||||
|
2025
Q1 | $118K | Sell |
|
|||||
|
2024
Q4 | $238K | Buy |
|
|||||
|
2024
Q3 | $12.4K | Buy |
|
|||||
|
2024
Q2 | $191 | Hold |
|
|||||
|
2024
Q1 | $217 | Hold |
|
|||||
|
2023
Q4 | $111 | Hold |
|
|||||
|
2023
Q3 | $424 | Hold |
|
|||||
|
2023
Q2 | $527 | Hold |
|
|||||
|
2023
Q1 | $637 | Hold |
|
|||||
|
2022
Q4 | $541 | Hold |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $9K | Buy |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $64K | Buy |
|